What is Imatinib?
CATEGORY: Prescription Drugs
Imatinib is an antineoplastic agent which inhibits BCR-ABL tyrosine kinase, the abnormal gene product of the Philadelphia chromosome in chronic myeloid leukemia. It is also used for Ph+ acute lymphoblastic leukemia (ALL) and gastrointestinal stromal tumors (GIST).
Save up to 80% off your prescriptions!
How do members experience Imatinib?
Top 5 reported purposes & perceived effectiveness
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Chronic myeloid leukemia | 107 | 16 | |
| Gastrointestinal stromal tumors | 30 | 5 | |
| Acute lymphocytic leukemia | 5 | 0 | |
| Dermatofibrosarcoma protuberans | 3 | 0 | |
| Mast cell activation syndrome | 2 | 1 |
Common side effects
| Side effect | Patients | Percentage |
|---|---|---|
| Diarrhea | 6 | |
| Nausea | 3 | |
| Elevated liver enzymes | 2 | |
| Fatigue | 2 | |
| Fluid retention (edema) | 2 | |
| Rashes (redness, swelling) | 2 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 3 | |
| Moderate | 6 | |
| Mild | 12 | |
| None | 2 |
Learn more about our community’s experience with Imatinib
What are people saying about Imatinib?
177
177
members have reported taking Imatinib
Join the conversation and connect with people who have taken Imatinib
Last updated: